A case of mandible Paget’s disease of the bone treated with intravenous neridronate

Published: December 16 2016
Abstract Views: 1986
PDF: 1015
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Paget’s disease of bone (PDB) is a focal disorder of osteoclasts, leading to chaotic bone remodelling, and it is characterized by the presence of focal areas of excessive bone formation alongside with areas of focal bone resorption. The typical radiographic feature is the cotton wool appearance. To date, bisphosphonates are the mainstay of the treatment. We hereby report the case of a young woman presenting with mandible PDB, with a relevant diagnostic delay and mistakenly treated for five years with chronic oral corticosteroids. After our evaluation, the patient received treatment with intravenous neridronate (an amino-bisphosphonate licensed in Italy for the treatment of this disease), with achievement of clinical remission.

Altmetrics

Downloads

Download data is not yet available.

Citations

How to Cite



A case of mandible Paget’s disease of the bone treated with intravenous neridronate. (2016). Reumatismo, 68(3), 154-158. https://doi.org/10.4081/reumatismo.2016.917

Similar Articles

1-10 of 596

You may also start an advanced similarity search for this article.